drugset
Drugs / Vi-TT
last change Dec 2024 re-read 3 minutes ago

Vi-TT

Vaccine

Developed for
typhoid fever
Investigated by
Fondation Mérieux · International Centre for Diarrhoeal Disease Research, Bangladesh · International Vaccine Institute · Kwame Nkrumah University of Science and Technology · University of Cambridge · University of Maryland, Baltimore

Trials 1

today NCT04852185 · Ph 4
20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT04852185 Aug 2021 → Dec 2024 typhoid fever International Vaccine Institute Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Vi-TT ClinicalTrials.gov intervention name — accepted as the source's own label NCT04852185 ↗
Modality Vaccine “Vi-Polysaccharide conjugate vaccine” NCT04852185 ↗